Miscellaneous antibacterial drugs

Jason M. Cota, Taylor M. Benavides

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Appraisal of available literature published from January 2019 to April 2020 yielded a total of 98 studies, 14 of which pertained to aminoglycosides, 26 to fluoroquinolones, 23 to glycopeptides, 3 to clindamycin, 13 to macrolides, 7 to oxazolidinones, 4 to polymyxins, 5 to trimethoprim/sulfamethoxazole, 2 to daptomycin, 1 to nitrofurantoin, 1 to fosfomycin, and 1 to lefamulin. Our search yielded no pertinent literature for tedizolid and for trimethoprim alone.

Original languageEnglish
Title of host publicationA Worldwide Yearly Survey of New Data in Adverse Drug Reactions
EditorsSidhartha D. Ray
PublisherElsevier B.V.
Number of pages14
ISBN (Print)9780128203309
StatePublished - Jan 2020

Publication series

NameSide Effects of Drugs Annual
ISSN (Print)0378-6080


  • Aminoglycosides
  • Clindamycin
  • Daptomycin
  • Fluoroquinolones
  • Glycopeptides
  • Lefamulin
  • Macrolides
  • Oxazolidinones
  • Polymyxins
  • Trimethoprim–sulfamethoxazole
  • Urinary antibiotics


Dive into the research topics of 'Miscellaneous antibacterial drugs'. Together they form a unique fingerprint.

Cite this